tiragolumab (rg6058, mtig7192a)

A novel immune checkpoint inhibitor

Tiragolumab is an investigational, fully human monoclonal IgG1 antibody designed to prevent PVR-TIGIT interaction¹

IgG1=immunoglobulin G1; PVR=poliovirus receptor; TIGIT=T-cell immunoreceptor with Ig and ITIM domains.